These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

903 related articles for article (PubMed ID: 17489882)

  • 1. Systematic review of the efficacy of antiretroviral therapies for reducing the risk of mother-to-child transmission of HIV infection.
    Suksomboon N; Poolsup N; Ket-Aim S
    J Clin Pharm Ther; 2007 Jun; 32(3):293-311. PubMed ID: 17489882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Brocklehurst P; Volmink J
    Cochrane Database Syst Rev; 2002; (2):CD003510. PubMed ID: 12076484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Brocklehurst P; Volmink J
    Cochrane Database Syst Rev; 2002; (1):CD003510. PubMed ID: 11869666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
    ; de Vincenzi I
    Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral interventions for preventing breast milk transmission of HIV.
    White AB; Mirjahangir JF; Horvath H; Anglemyer A; Read JS
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD011323. PubMed ID: 25280769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral therapy for prevention of mother-to-child HIV transmission : focus on single-dose nevirapine.
    Giaquinto C; Rampon O; De Rossi A
    Clin Drug Investig; 2006; 26(11):611-27. PubMed ID: 17163296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short postexposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1: NVAZ randomised clinical trial.
    Taha TE; Kumwenda NI; Gibbons A; Broadhead RL; Fiscus S; Lema V; Liomba G; Nkhoma C; Miotti PG; Hoover DR
    Lancet; 2003 Oct; 362(9391):1171-7. PubMed ID: 14568737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study.
    Thior I; Lockman S; Smeaton LM; Shapiro RL; Wester C; Heymann SJ; Gilbert PB; Stevens L; Peter T; Kim S; van Widenfelt E; Moffat C; Ndase P; Arimi P; Kebaabetswe P; Mazonde P; Makhema J; McIntosh K; Novitsky V; Lee TH; Marlink R; Lagakos S; Essex M;
    JAMA; 2006 Aug; 296(7):794-805. PubMed ID: 16905785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial.
    Jackson JB; Musoke P; Fleming T; Guay LA; Bagenda D; Allen M; Nakabiito C; Sherman J; Bakaki P; Owor M; Ducar C; Deseyve M; Mwatha A; Emel L; Duefield C; Mirochnick M; Fowler MG; Mofenson L; Miotti P; Gigliotti M; Bray D; Mmiro F
    Lancet; 2003 Sep; 362(9387):859-68. PubMed ID: 13678973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antivirals for prevention of hepatitis B virus mother-to-child transmission in human immunodeficiency virus positive pregnant women co-infected with hepatitis B virus.
    Ugwu EO; Eleje GU; Ugwu AO; Nwagha UI; Ikechebelu JI; Umeh UA; Okafor HU
    Cochrane Database Syst Rev; 2023 Jun; 6(6):CD013653. PubMed ID: 37306558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.
    Moodley D; Moodley J; Coovadia H; Gray G; McIntyre J; Hofmyer J; Nikodem C; Hall D; Gigliotti M; Robinson P; Boshoff L; Sullivan JL;
    J Infect Dis; 2003 Mar; 187(5):725-35. PubMed ID: 12599045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zidovudine: a review of its use in the management of vertically-acquired pediatric HIV infection.
    Bhana N; Ormrod D; Perry CM; Figgitt DP
    Paediatr Drugs; 2002; 4(8):515-53. PubMed ID: 12126455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial.
    Guay LA; Musoke P; Fleming T; Bagenda D; Allen M; Nakabiito C; Sherman J; Bakaki P; Ducar C; Deseyve M; Emel L; Mirochnick M; Fowler MG; Mofenson L; Miotti P; Dransfield K; Bray D; Mmiro F; Jackson JB
    Lancet; 1999 Sep; 354(9181):795-802. PubMed ID: 10485720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind, placebo-controlled trial of combined nevirapine and zidovudine compared with nevirapine alone in the prevention of perinatal transmission of HIV in Zimbabwe.
    Thistle P; Spitzer RF; Glazier RH; Pilon R; Arbess G; Simor A; Boyle E; Chitsike I; Chipato T; Gottesman M; Silverman M
    Clin Infect Dis; 2007 Jan; 44(1):111-9. PubMed ID: 17143826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
    Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F
    Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interventions for reducing the risk of mother-to-child transmission of HIV infection.
    Brocklehurst P
    Cochrane Database Syst Rev; 2002; (1):CD000102. PubMed ID: 11869564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial.
    Taha TE; Kumwenda NI; Hoover DR; Fiscus SA; Kafulafula G; Nkhoma C; Nour S; Chen S; Liomba G; Miotti PG; Broadhead RL
    JAMA; 2004 Jul; 292(2):202-9. PubMed ID: 15249569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.